BlackRock’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $1.18M | Sell |
|
|||||
2022
Q4 | $790K | Sell |
|
|||||
2022
Q3 | $1.85M | Sell |
|
|||||
2022
Q2 | $3.01M | Sell |
|
|||||
2022
Q1 | $6.99M | Buy |
|
|||||
2021
Q4 | $11.2M | Sell |
|
|||||
2021
Q3 | $25.2M | Buy |
|
|||||
2021
Q2 | $48.2M | Sell |
|
|||||
2021
Q1 | $67.7M | Buy |
|
|||||
2020
Q4 | $80.5M | Buy |
|
|||||
2020
Q3 | $42.8M | Buy |
|
|||||
2020
Q2 | $16.8M | Buy |
|
|||||
2020
Q1 | $6.92M | Buy |
|
|||||
2019
Q4 | $12.7M | Buy |
|
|||||
2019
Q3 | $12.5M | Buy |
|
|||||
2019
Q2 | $1.51M | Buy |
|